^
BIOMARKER:
FGFR2 mutation
i
Other names: FGFR2, BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25, Fibroblast growth factor receptor 2
Entrez ID:
FGFR2 mutation
Urothelial Cancer
erdafitinib
Sensitive
:
A1
FGFR2 mutation
Cholangiocarcinoma
erdafitinib
Sensitive
:
C1
FGFR2 mutation
Gastric Cancer
erdafitinib
Sensitive
:
C1
FGFR2 mutation
Cholangiocarcinoma
BGJ398
Sensitive
:
C2
FGFR2 mutation
Cholangiocarcinoma
ARQ 087
Sensitive
:
C2
FGFR2 mutation
Cholangiocarcinoma
TAS 120
Sensitive
:
C2
FGFR2 mutation
NSCLC
Immunotherapy
Sensitive
:
C3
FGFR2 mutation
NSCLC
nintedanib
Sensitive
:
C3
FGFR2 mutation
Cholangiocarcinoma
pemigatinib
Sensitive
:
C3
FGFR2 mutation
Cholangiocarcinoma
FGFR2 inhibitor
Resistant
:
C3
FGFR2 mutation
Solid Tumor
CPL304110
Sensitive
:
D
FGFR2 mutation
Multiple Myeloma
BGJ398
Sensitive
:
D
FGFR2 mutation
Endometrial Cancer
BGJ398
Sensitive
:
D
FGFR2 mutation
Endometrial Cancer
PD 0173074
Sensitive
:
D
FGFR2 mutation
Endometrial Cancer
fulvestrant + TKI258
Sensitive
:
D
FGFR2 mutation
Estrogen Receptor Positive Breast Cancer
fulvestrant
Resistant
:
D
FGFR2 mutation
Estrogen Receptor Positive Breast Cancer
palbociclib
Resistant
:
D
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our